Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 3/20 | 0.48 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.45 |
| ▸ | ACACB | O00763 | 7/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7449579 | 1.00 | F10 (0.48) | F10ITGB3ITGA2BACACBHRH3 | |
| SCHEMBL7327020 | 0.89 | ACACB (0.47) | F10ITGB3ITGA2BACACB | |
| SCHEMBL7327023 | 0.89 | ACACB (0.47) | F10ITGB3ITGA2BACACB | |
| Hydrochloric Acid SCHEMBL7329134 | 0.88 | F10 (0.47) | F10ITGB3ITGA2BACACB | |
| Hydrochloric Acid SCHEMBL7329132 | 0.88 | F10 (0.47) | F10ITGB3ITGA2BACACB | |
| SCHEMBL7398432 | 0.84 | F10 (0.48) | F10ITGB3ITGA2B | |
| SCHEMBL7398480 | 0.81 | ITGB3 (0.53) | F10ITGB3ITGA2BHRH3 | |
| SCHEMBL27461789 | 0.80 | FFAR4 (0.52) | F10ITGB3ITGA2BHRH3 | |
| SCHEMBL2923427 | 0.79 | PARP10 (0.58) | ITGB3ITGA2BACACB | |
| SCHEMBL2923430 | 0.79 | PARP10 (0.58) | ITGB3ITGA2BACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0691959-B1 | HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS | ZENECA LTD (GB) | 1998-07-22 | — | — | EP | disclosed |
| EP-0825184-A1 | Heterocyclic derivatives as platelet aggregation inhibitors | ZENECA LIMITED (GB) | 1998-02-25 | — | — | EP | disclosed |